A.R.T. Advisors’s Pfizer PFE Stock Holding History

A.R.T. Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-8,571	Closed	-$336K	–	11
2021 Q2	$336K	Buy	+8,571	New	+$333K	14.58%	3
2017 Q4	–	Sell	-28,353	Closed	-$960K	–	1594
2017 Q3	$960K	Buy	+28,353	New	+$911K	0.05%	553
2016 Q2	–	Sell	-681,448	Closed	-$19.2M	–	1565
2016 Q1	$19.2M	Buy	681,448 +576,948	+552%	+$16.5M	0.86%	4
2015 Q4	$3.2M	Buy	+104,500	New	+$3.29M	0.15%	165
2014 Q3	–	Sell	-317,723	Closed	-$8.95M	–	1477
2014 Q2	$8.95M	Buy	+317,723	New	+$9.06M	0.47%	20
2014 Q1	–	Sell	-445,361	Closed	-$12.9M	–	1502
2013 Q4	$12.9M	Buy	+445,361	New	+$13M	0.69%	6

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

A.R.T. Advisors's PFE Position: Q3 2021 in Review

A.R.T. Advisors sold out of Pfizer (PFE) in Q3 2021, closing a stake of 8,571 shares — an estimated $336K sold.

A.R.T. Advisors first reported a position in PFE in Q4 2013 and held it in 6 quarters. The position peaked at $19.2M in Q1 2016. 2,803 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

A.R.T. Advisors reported no remaining Pfizer position as of Q3 2021 after selling out during the quarter.
A.R.T. Advisors sold 8,571 Pfizer shares in Q3 2021, an estimated $336K.
A.R.T. Advisors first reported a position in Pfizer in Q4 2013 and held it in 6 quarters.
A.R.T. Advisors's Pfizer position peaked at $19.2M in Q1 2016.
2,803 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on A.R.T. Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.